{
  "cik": 2046386,
  "cik_padded": "0002046386",
  "entityName": "Medline Inc.",
  "fiscal_years": [
    {
      "accn": "0002046386-26-000009",
      "filed": "2026-02-25",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 33000000.0,
        "capex": 447000000.0,
        "cash": 1939000000.0,
        "cost_of_revenue": 20914000000.0,
        "eps_diluted": -0.01,
        "free_cash_flow": 1297000000.0,
        "gross_profit": 7518000000.0,
        "net_income": 1159000000.0,
        "operating_cash_flow": 1744000000.0,
        "operating_income": 2212000000.0,
        "revenue": 28432000000.0,
        "stockholders_equity": 10737000000.0,
        "total_assets": 38484000000.0,
        "total_liabilities": 19198000000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "leverage": "ratio",
        "net_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "gross_margin": 0.26442037141249297,
        "leverage": 1.7880227251560026,
        "net_margin": 0.04076392796848621,
        "operating_margin": 0.07779966235227913,
        "revenue_growth_yoy": 0.11467440310502999,
        "roa_avg2y": 0.03112997233488222,
        "roa_period_end": 0.030116412015383016,
        "roe_period_end": 0.10794449101238707
      }
    },
    {
      "accn": "0002046386-26-000009",
      "filed": "2026-02-25",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "capex": "USD",
        "cash": "USD",
        "cost_of_revenue": "USD",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "buybacks": 20000000.0,
        "capex": 354000000.0,
        "cash": 199000000.0,
        "cost_of_revenue": 18531000000.0,
        "free_cash_flow": 1415000000.0,
        "gross_profit": 6976000000.0,
        "operating_cash_flow": 1769000000.0,
        "operating_income": 2146000000.0,
        "revenue": 25507000000.0,
        "total_assets": 35978000000.0,
        "total_liabilities": 19454000000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "operating_margin": "ratio",
        "revenue_growth_yoy": "ratio"
      },
      "ratios": {
        "gross_margin": 0.2734935507899792,
        "operating_margin": 0.08413376720116046,
        "revenue_growth_yoy": 0.09797253669665533
      }
    },
    {
      "accn": "0002046386-26-000009",
      "filed": "2026-02-25",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "buybacks": "USD",
        "capex": "USD",
        "cost_of_revenue": "USD",
        "free_cash_flow": "USD",
        "gross_profit": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD"
      },
      "fundamentals": {
        "buybacks": 0.0,
        "capex": 275000000.0,
        "cost_of_revenue": 17346000000.0,
        "free_cash_flow": 1410000000.0,
        "gross_profit": 5885000000.0,
        "operating_cash_flow": 1685000000.0,
        "operating_income": 1250000000.0,
        "revenue": 23231000000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "gross_margin": "ratio",
        "operating_margin": "ratio"
      },
      "ratios": {
        "gross_margin": 0.2533252980930653,
        "operating_margin": 0.05380741250914726
      }
    }
  ],
  "latest_filing": {
    "accn": "0002046386-26-000009",
    "filed": "2026-02-25",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "3841",
  "sic_description": "Surgical & Medical Instruments & Apparatus",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0002046386.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0002046386.json"
  },
  "ticker": "MDLN"
}